Clemens JQ, Link CL, Eggers PW, et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol. 2007;177(4):1390-1394.
Joint terminology report: terminology standardization for female bladder pain syndrome. Int Urogynecol J. 2025;36(2):265-277.
Clemens JQ, Erickson DR, Varela NP, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34-42.
Wyndaele JJJ, Riedl C, Taneja R, et al. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2019;38(2):535-544.
Akiyama Y, Hanno P. Phenotyping of interstitial cystitis/bladder pain syndrome. Int J Urol. 2019;26(suppl 1):17-19.
Imamura M, Scott NW, Wallace SA, et al. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis. Cochrane Database Syst Rev. 2020(7):CD013325.
Teichman JM, Parsons CL. Contemporary clinical presentation of interstitial cystitis. Urology. 2007;69(4 suppl):41-47.
Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology. 2007;69(4suppl):64-72.
Management of bladder pain syndrome: green-top guideline no. 70. BJOG. 2017;124(2):e46-e72.
van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60-67.
Humphrey L, Arbuckle R, Moldwin R, et al. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. Eur Urol. 2012;61(2):271-279.
Clemens JQ, Calhoun EA, Litwin MS, et al. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology. 2009;74(5):983-987 , quiz 987.e1–987.e3.
Lubeck DP, Whitmore K, Sant GR, et al. Psychometric validation of the O’Leary-Sant Interstitial Cystitis Symptom Index in a clinical trial of pentosan polysulfate sodium. Urology. 2001;57(6 suppl 1):62-66.
Brewer ME, White WM, Klein FA, et al. Validity of Pelvic Pain, Urgency, and Frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome. Urology. 2007;70(4):646-649.
Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med. 1998;5(11):1086-1090.
Kim SH, Oh SA, Oh SJ. Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder. Int J Urol. 2014;21(2):179-183.
Boudry G, Labat JJ, Riant T, et al. Validation of voiding diary for stratification of bladder pain syndrome according to the presence/absence of cystoscopic abnormalities: a two-centre prospective study. BJU Int. 2013;112(2):E164-E168.
Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109(11):1584-1591.
Powell-Boone T, Ness TJ, Cannon R, et al. Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis. J Urol. 2005;174(5):1832-1836.
Naliboff BD, Schrepf AD, Stephens-Shields AJ, et al. Temporal relationships between pain, mood and urinary symptoms in urological chronic pelvic pain syndrome: a MAPP Network Study. J Urol. 2021;205(6):1698-1703.
Clemens JQ, Stephens-Shields AJ, Newcomb C, et al. Correlates of 1-year change in quality of life in patients with urologic chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. J Urol. 2020;204(4):754-759.
Bosch PC. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome. Urology. 2014;84(2):321-326.
Lee MH, Wu HC, Lin JY, et al. Development and evaluation of an E-health system to care for patients with bladder pain syndrome/interstitial cystitis. Int J Urol. 2014;21(suppl 1):62-68.
Kim EK, Brown LA, Hartzell-Leggin D, et al. Algorithm-based mobile texting platform for the self-management of interstitial cystitis/bladder pain syndrome: pilot study evaluating feasibility, usability, and potential utility. Urol Pract. 2025;12(2):203-213.
Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. J Urol. 1993;149(6):1445-1448.
Starzec-Proserpio M, Frawley H, Bø K, et al. Effectiveness of nonpharmacological conservative therapies for chronic pelvic pain in women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025;232(1):42-71.
Jarman A, Janes JL, Shorter B, et al. Food sensitivities in a diverse nationwide cohort of veterans with interstitial cystitis/bladder pain syndrome. J Urol. 2023;209(1):216-224.
- ICN food list. Interstitial Cystitis Network. Accessed March 21, 2025. https://www.chronicpelvicpain.org/wp-content/uploads/2025/01/2025foodlist.pdf
Dao AN, Komesu YM, Jansen SM, et al. Augmentation of interstitial cystitis-bladder pain syndrome treatment with meditation and yoga: a randomized controlled trial. Obstet Gynecol. 2025;145(2):186-195.
Yu WR, Jhang JF, Chen BY, et al. Multimodal treatment with cognitive behavioral therapeutic intervention plus bladder treatment is more effective than monotherapy for patients with interstitial cystitis/bladder pain syndrome—a randomized clinical trial. J Clin Med. 2022;11(20):6221.
Kanter G, Komesu YM, Qaedan F, et al. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Int Urogynecol J. 2016;27(11):1705-1711.
Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207-212.
Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49(5A suppl):108-110.
Sant GR, Propert KJ, Hanno PM, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810-815.
Sasaki K, Smith CP, Chuang YC, et al. Oral gabapentin (Neurontin) treatment of refractory genitourinary tract pain. Tech Urol. 2001;7(1):47-49.
Moldwin RM, Evans RJ, Stanford EJ, et al. Rational approaches to the treatment of patients with interstitial cystitis. Urology. 2007;69(4 suppl):73-81.
van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533-536.
Portman DJ, Gass MLS; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-1068.
Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202(2):282-289.
Grigoryan B, Kasyan G, Pivazyan L, et al. Pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis with Hunner’s lesions or glomerulations: systematic review and meta-analysis. Ther Adv Urol. 2022;14 : 17562872221102809.
van Ophoven A, Vonde K, Koch W, et al. Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials. Curr Med Res Opin. 2019;35(9):1495-1503.
McGwin G, MacLennan P, Owsley C. Association between pentosan polysulfate sodium and retinal disorders. JAMA Ophthalmol. 2022;140(1):37-42.
Sairanen J, Tammela TLJ, Leppilahti M, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235-2238.
Crescenze IM, Tucky B, Li J, et al. Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome. Urology. 2017;107:49-54.
Liu S, Zhang C, Peng L, et al. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32(5):1061-1071.
Doiron RC, Tolls V, Irvine-Bird K, et al. Clinical phenotyping does not differentiate Hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol. 2016;196(4):1136-1140.
Aihara K, Hirayama A, Tanaka N, et al. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol. 2009;16(12):947-952.
Hoke TP, Goldstein H, Saks EK, et al. Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC). Neurourol Urodyn. 2017;36(3):784-786.
Wang J, Chen Y, Chen J, et al. Sacral neuromodulation for refractory bladder pain syndrome/interstitial cystitis: a global systematic review and meta-analysis. Sci Rep. 2017;7(1):11031.
Giannantoni A, Porena M, Costantini E, et al. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol. 2008;179(3):1031-1034.
Patil S, Daniel G, Tailor Y, et al. Bladder pain syndrome/interstitial cystitis response to nerve blocks and trigger point injections. BJUI Compass. 2022;3(6):450-457.
Verghese TS, Riordain RN, Champaneria R, et al. Complementary therapies for bladder pain syndrome: a systematic review. Int Urogynecol J. 2016;27(8):1127-1136.
Jones HG, Rizzo RRN, Pulling BW, et al. Adjunctive use of hypnosis for clinical pain: a systematic review and meta-analysis. Pain Rep. 2024;9(5):e1185.
Metts JF. Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician. 2001;64(7):1199-1206.
French LM, Bhambore N. Interstitial cystitis/painful bladder syndrome. Am Fam Physician. 2011;83(10):1175-1181.